A new guideline recommends that statins alone or in combination with ezetimibe not be initiated in adult dialysis patients.
Better outcomes observed with more frequent and longer dialysis sessions.
Patients found to have a 67% increased risk of coronary events or death compared with patients who did not suffer acute kidney injury.
The Canadian Society of Nephrology recommends initiation when clinical indications emerge or when the eGFR 6 mL/min/1.73 m2 or below.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
This trait in African-American hemodialysis patients was associated with a 13.2% higher dose of erythropoiesis-stimulating agents.
The adjusted rate fell 26.5% from 1996 to 2011, but remains much higher than in the general population.
New meta-analysis shows no significant increase in hemoglobin or decrease in required erythropoietin dose.
Sexual inactivity is common but not bothersome to many women, study shows.
Renal tissue could one day be created that would be functional as well as completely immunocompatible.
Levels of bisphenol A in components of dialysis machines may be toxic to immune cells circulating in hemodialysis patients.
Hemodialysis and peritoneal dialysis patients are more likely than non-dialysis patients to suffer an ischemic or hemorrhagic stroke.
Starting dialysis after conception, not before, may improve birth rates in women with end-stage renal disease.
Receiving nocturnal dialysis may decrease the risk of heart disease in patients with end-stage renal disease.
Shorter survival found among patients who had intensive procedures and started dialysis in the hospital.
Common genetic polymorphisms may explain patterns in vitamin D status in blacks.
Behavioral therapy provided chair-side to kidney failure patients while they are undergoing dialysis may help fight depression.
Agency releases a video, a poster, and a pocket guide to help providers and patients prevent development of infectious complications in patients undergoing hemodialysis.
Elemental iron requirement was reduced by half in patients receiving ferric citrate versus an active control.
New findings are based on a study of 472 patients with stage 4-5 chronic kidney disease.
Weekly dose of erythropoiesis-stimulating agents decreased and hemoglobin levels increased.
Their presence is associated with a greater than threefold increased risk.
A transferrin saturation of 20% or less was associated with a 2.2 times increased risk of death from any cause.
Study also documents use of higher IV iron doses and declining hemoglobin levels.
Results show an increased risk of mortality and hospitalizations compared with late starts.
Low phosphorus increases all-cause and cardiovascular mortality only among the elderly.
They have a higher inpatient mortality risk and longer lengths of stay compared with those admitted on weekdays.
Over the past 10 years the annual ESRD incidence rate per million U.S. population has remained stagnant or even shown sporadic downward trends.
A new analysis has concluded that large numbers of dialysis patients are inappropriately being prescribed statins to lower their cholesterol.
Dialysis centers are reimbursed a flat amount to cover almost all the costs of providing care to dialysis patients.